Bayer Schering Pharma

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its pharmaceutical division, formerly known as Bayer Schering Pharma following the 2006 acquisition of Schering AG, focuses on prescription products for cardiology, oncology, gynecology, hematology, and ophthalmology. The company is a leader in the development of small molecules and biologics, with a growing portfolio in cell and gene therapies through its subsidiaries BlueRock Therapeutics and AskBio. Key products include the anticoagulant Xarelto, the ophthalmology drug Eylea, and the cancer treatment Nubeqa. Bayer is headquartered in Leverkusen, Germany, and operates a major research and development hub for its pharmaceutical business in Berlin.